This Article Full Text (OnlineFirst PDF) All Versions of this Article: 8756479309333108v1 25/2/101    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Perry, C. L. Search for Related Content Social Bookmarking                         What's this?

Sonographic Evaluation of Neuroblastoma

^* To whom correspondence should be addressed. E-mail: clp4h9{at}mizzou.edu.

	Abstract

Neuroblastoma is a malignancy arising from the sympathetic nervous system that accounts for approximately 7% of childhood cancers. Most occur between the ages of 2 months and 2 years. The majority arises in the adrenal medulla but may also occur in the neck, chest, or pelvis. Diagnostic medical sonography is a significant imaging tool that involves no radiation exposure for detecting neuroblastoma. Further imaging studies are needed so that the stage and spread of the disease can be determined. Factors including age, MYCN (v-myc myelocytomatosis viral-related oncogene) amplification, and stage are used to determine treatment and prognosis of a child with neuroblastoma. This case demonstrates the sonographic findings of an 8-monthold child with stage IV neuroblastoma.

First published on March 31, 2009, doi:10.1177/8756479309333108

Journal of Diagnostic Medical Sonography 2009;25:101.

A more recent version of this article appeared on March 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?